Improving Medication Management in World Trade Center Responders

ID#: NCT07022990

Age: 50 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: April 08, 2025

End Date: June 30, 2026

Contact Information:
Patricia Kim
212-241-9370
Summary: By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Eligibility:

Inclusion Criteria:

- A WTC responder already enrolled in the "Promoting Healthy Aging Among WTC Responders: Frailty Trajectories and Intervention Strategies" study cohort

- aged 50 years or older, and

- taking one of the five medication classes:

- proton pump inhibitors (PPIs),

- benzodiazepine (BZs) and

- non-benzodiazepine sedative hypnotics ("Z-drugs"),

- first-generation antihistamines (FGA), and

- skeletal muscle relaxants (SMR).

Exclusion Criteria:

- None
Find a Clinical Trial Find Cancer Clinical Trials